{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:32:49Z","timestamp":1788913969147,"version":"build-2803163510"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Tianjin Key Medical Discipline(Specialty) Construction Project","award":["TJYXZDXK-012A"],"award-info":[{"award-number":["TJYXZDXK-012A"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82002813"],"award-info":[{"award-number":["82002813"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-02340-6","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T10:39:08Z","timestamp":1744886348000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Integrative genomic pan-cancer analysis reveals the prognostic significance of DEFB1 in tumors"],"prefix":"10.1007","volume":"16","author":[{"given":"Li","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,17]]},"reference":[{"issue":"2","key":"2340_CR1","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.cell.2018.03.059","volume":"173","author":"A Blum","year":"2018","unstructured":"Blum A, Wang P, Zenklusen JC. SnapShot TCGA-analyzed tumors. Cell. 2018;173(2):530. https:\/\/doi.org\/10.1016\/j.cell.2018.03.059.","journal-title":"Cell"},{"issue":"1A","key":"2340_CR2","doi-asserted-by":"publisher","first-page":"A68","DOI":"10.5114\/wo.2014.47136","volume":"19","author":"K Tomczak","year":"2015","unstructured":"Tomczak K, Czerwinska P, Wiznerowicz M. The Cancer genome atlas (TCGA): an immeasurable source of knowledge. Contemp Oncol (Pozn). 2015;19(1A):A68-77. https:\/\/doi.org\/10.5114\/wo.2014.47136.","journal-title":"Contemp Oncol (Pozn)"},{"key":"2340_CR3","doi-asserted-by":"publisher","first-page":"3096","DOI":"10.2174\/138161207782110381","volume":"13","author":"M Pazgier","year":"2007","unstructured":"Pazgier M, Li X, Lu W, et al. Human defensins: synthesis and structural properties. Curr Pharm Des. 2007;13:3096\u2013118. https:\/\/doi.org\/10.2174\/138161207782110381.","journal-title":"Curr Pharm Des"},{"key":"2340_CR4","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1007\/s00018-005-5540-2","volume":"63","author":"M Pazgier","year":"2006","unstructured":"Pazgier M, Hoover DM, Yang D, et al. Human \u03b2-defensins. Cell Mol Life Sci. 2006;63:1294\u2013313. https:\/\/doi.org\/10.1007\/s00018-005-5540-2.","journal-title":"Cell Mol Life Sci"},{"key":"2340_CR5","doi-asserted-by":"publisher","first-page":"3952","DOI":"10.1073\/pnas.88.9.3952","volume":"88","author":"G Diamond","year":"1991","unstructured":"Diamond G, Zasloff M, Eck H, et al. Tracheal antimicrobial peptide, a cysteine-rich peptide from mammalian tracheal mucosa: peptide isolation and cloning of a cDNA. Proc Natl Acad Sci USA. 1991;88:3952\u20136. https:\/\/doi.org\/10.1073\/pnas.88.9.3952.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2340_CR6","doi-asserted-by":"publisher","first-page":"6641","DOI":"10.1016\/S0021-9258(18)53298-1","volume":"268","author":"ME Selsted","year":"1993","unstructured":"Selsted ME, Tang YQ, Morris WL, et al. Purification, primary structures, and antibacterial activities of beta-defensins, a new family of antimicrobial peptides from bovine neutrophils. J Biol Chem. 1993;268:6641\u20138.","journal-title":"J Biol Chem"},{"key":"2340_CR7","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/0014-5793(95)00687-5","volume":"368","author":"KW Bensch","year":"1995","unstructured":"Bensch KW, Raida M, M\u00e4gert HJ, et al. hBD-1: a novel \u03b2-defensin from human plasma. FEBS Lett. 1995;368:331\u20135. https:\/\/doi.org\/10.1016\/0014-5793(95)00687-5.","journal-title":"FEBS Lett"},{"issue":"6","key":"2340_CR8","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.biocel.2010.01.021","volume":"42","author":"PMD Oca","year":"2010","unstructured":"Oca PMD. Human beta-defensin 1: a restless warrior against allergies, infections and cancer. Int J Biochem Cell Biol. 2010;42(6):800\u20134. https:\/\/doi.org\/10.1016\/j.biocel.2010.01.021.","journal-title":"Int J Biochem Cell Biol"},{"key":"2340_CR9","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.biocel.2018.09.007","volume":"104","author":"\u00c1H \u00c1lvarez","year":"2018","unstructured":"\u00c1lvarez \u00c1H, Mart\u00ednez VM, Prado MDOE. Human \u03b2-defensin 1 update: potential clinical applications of the restless warrior. Int J Biochem Cell Biol. 2018;104:133\u20137. https:\/\/doi.org\/10.1016\/j.biocel.2018.09.007.","journal-title":"Int J Biochem Cell Biol"},{"issue":"6","key":"2340_CR10","doi-asserted-by":"publisher","first-page":"5268","DOI":"10.3390\/ijms24065268","volume":"24","author":"L Adyns","year":"2023","unstructured":"Adyns L, Proost P, Struyf S. Role of defensins in tumor biology. Int J Mol Sci. 2023;24(6):5268. https:\/\/doi.org\/10.3390\/ijms24065268.","journal-title":"Int J Mol Sci"},{"key":"2340_CR11","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1097\/01.lab.0000063929.61760.f6","volume":"83","author":"CD Donald","year":"2003","unstructured":"Donald CD, Sun CQ, Lim SD, et al. Cancer-specific loss of \u03b2-defensin 1 in renal and prostatic carcinomas. Lab Invest. 2003;83:501\u20135. https:\/\/doi.org\/10.1097\/01.lab.0000063929.61760.f6.","journal-title":"Lab Invest"},{"key":"2340_CR12","doi-asserted-by":"publisher","first-page":"8542","DOI":"10.1158\/0008-5472.CAN-06-0294","volume":"66","author":"CQ Sun","year":"2006","unstructured":"Sun CQ, Arnold R, Fernandez-Golarz C, et al. Human \u03b2-defensin-1, a potential chromosome 8p tumor suppressor: control of transcription and induction of apoptosis in renal cell carcinoma. Cancer Res. 2006;66:8542\u20139. https:\/\/doi.org\/10.1158\/0008-5472.CAN-06-0294.","journal-title":"Cancer Res"},{"key":"2340_CR13","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1080\/15384047.2018.1564564","volume":"20","author":"CQ Sun","year":"2019","unstructured":"Sun CQ, Arnold RS, Hsieh CL, et al. Discovery and mechanisms of host defense to oncogenesis: targeting the \u03b2-defensin-1 peptide as a natural tumor inhibitor. Cancer Biol Ther. 2019;20:774\u201386. https:\/\/doi.org\/10.1080\/15384047.2018.1564564.","journal-title":"Cancer Biol Ther"},{"key":"2340_CR14","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/1471-2407-6-163","volume":"6","author":"T Gambichler","year":"2006","unstructured":"Gambichler T, Skrygan M, Huyn J, et al. Pattern of mRNA expression of \u03b2-defensins in basal cell carcinoma. BMC Cancer. 2006;6:163. https:\/\/doi.org\/10.1186\/1471-2407-6-163.","journal-title":"BMC Cancer"},{"key":"2340_CR15","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1111\/j.1365-2133.2012.11110.x","volume":"167","author":"N Scola","year":"2012","unstructured":"Scola N, Gambichler T, Saklaoui H, et al. The expression of antimicrobial peptides is significantly altered in cutaneous squamous cell carcinoma and precursor lesions: antimicrobial peptides in squamous cell carcinoma and precursor lesions. Br J Dermatol. 2012;167:591\u20137. https:\/\/doi.org\/10.1111\/j.1365-2133.2012.11110.x.","journal-title":"Br J Dermatol"},{"key":"2340_CR16","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1111\/j.1399-302X.2009.00512.x","volume":"24","author":"S Joly","year":"2009","unstructured":"Joly S, Compton LM, Pujol C, et al. Loss of human beta-defensin 1, 2, and 3 expression in oral squamous cell carcinoma. Oral Microbiol Immunol. 2009;24:353\u201360. https:\/\/doi.org\/10.1111\/j.1399-302X.2009.00512.x.","journal-title":"Oral Microbiol Immunol"},{"key":"2340_CR17","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.ijom.2008.02.003","volume":"37","author":"M Wenghoefer","year":"2008","unstructured":"Wenghoefer M, Pantelis A, Dommisch H, et al. Decreased gene expression of human \u03b2-defensin-1 in the development of squamous cell carcinoma of the oral cavity. Int J Oral Maxillofac Surg. 2008;37:660\u20133. https:\/\/doi.org\/10.1016\/j.ijom.2008.02.003.","journal-title":"Int J Oral Maxillofac Surg"},{"key":"2340_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0126868","volume":"10","author":"A Semlali","year":"2015","unstructured":"Semlali A, Al Amri A, Azzi A, et al. Expression and new exon mutations of the human beta defensins and their association on colon cancer development. PLoS ONE. 2015;10: e0126868. https:\/\/doi.org\/10.1371\/journal.pone.0126868.","journal-title":"PLoS ONE"},{"issue":"6352","key":"2340_CR19","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1126\/science.aan2507","volume":"357","author":"M Uhlen","year":"2017","unstructured":"Uhlen M, Zhang C, Lee S, et al. A pathology atlas of the human cancer transcriptome. Science. 2017;357(6352):2507. https:\/\/doi.org\/10.1126\/science.aan2507.","journal-title":"Science."},{"issue":"W1","key":"2340_CR20","doi-asserted-by":"publisher","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","volume":"48","author":"T Li","year":"2020","unstructured":"Li T, Fu J, Zeng Z, et al. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 2020;48(W1):W509\u201314. https:\/\/doi.org\/10.1093\/nar\/gkaa407.","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"2340_CR21","doi-asserted-by":"publisher","first-page":"W556","DOI":"10.1093\/nar\/gkz430","volume":"47","author":"T Zefang","year":"2019","unstructured":"Zefang T, Boxi K, Chenwei L, et al. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. 2019;47(W1):W556\u201360. https:\/\/doi.org\/10.1093\/nar\/gkz430.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2340_CR22","doi-asserted-by":"publisher","first-page":"5679","DOI":"10.1038\/s41467-019-13528-0","volume":"10","author":"F Chen","year":"2019","unstructured":"Chen F, Chandrashekar DS, Varambally S, et al. Pan-cancer molecular subtypes revealed by mass-spectrometry-based proteomic characterization of more than 500 human cancers. Nat Commun. 2019;10(1):5679. https:\/\/doi.org\/10.1038\/s41467-019-13528-0.","journal-title":"Nat Commun"},{"issue":"269","key":"2340_CR23","doi-asserted-by":"publisher","first-page":"l1","DOI":"10.1126\/scisignal.200408","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao J, Aksoy BA, Dogrusoz U, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6(269):l1. https:\/\/doi.org\/10.1126\/scisignal.200408.","journal-title":"Sci Signal."},{"key":"2340_CR24","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/978-1-4939-7015-5_15","volume":"1611","author":"I Abugessaisa","year":"2017","unstructured":"Abugessaisa I, Noguchi S, Carninci P, Kasukawa T. The FANTOM5 computation ecosystem: genomic information hub for promoters and active enhancers. Methods Mol Biol. 2017;1611:199\u2013217. https:\/\/doi.org\/10.1007\/978-1-4939-7015-5_15.","journal-title":"Methods Mol Biol"},{"key":"2340_CR25","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.molimm.2006.11.026","volume":"45","author":"RS Bullard","year":"2008","unstructured":"Bullard RS, Gibson W, Bose SK, et al. Functional analysis of the host defense peptide human beta defensin-1: new insight into its potential role in cancer. Mol Immunol. 2008;45:839\u201348. https:\/\/doi.org\/10.1016\/j.molimm.2006.11.026.","journal-title":"Mol Immunol"},{"key":"2340_CR26","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1111\/apm.12749","volume":"125","author":"SA Hong","year":"2017","unstructured":"Hong SA, Kim KH, Lee TJ, et al. A role of human beta defensin-1 in predicting prostatic adenocarcinoma in cases of false-negative biopsy. APMIS. 2017;125:1063\u20139. https:\/\/doi.org\/10.1111\/apm.12749.","journal-title":"APMIS"},{"key":"2340_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0091867","volume":"9","author":"Q Han","year":"2014","unstructured":"Han Q, Wang R, Sun C, et al. Human beta-defensin-1 suppresses tumor migration and invasion and is an independent predictor for survival of oral squamous cell carcinoma patients. PLoS ONE. 2014;9: e91867. https:\/\/doi.org\/10.1371\/journal.pone.0091867.","journal-title":"PLoS ONE"},{"key":"2340_CR28","doi-asserted-by":"publisher","first-page":"2203615","DOI":"10.1155\/2022\/2203615","volume":"2022","author":"S Li","year":"2022","unstructured":"Li S, Li H, Xu Y, et al. Implications of human antimicrobial peptide defensin beta-1 in clinical oral squamous cell carcinoma patients via an integrated bioinformatics approach. Comput Math Methods Med. 2022;2022:2203615. https:\/\/doi.org\/10.1155\/2022\/2203615.","journal-title":"Comput Math Methods Med"},{"key":"2340_CR29","doi-asserted-by":"publisher","first-page":"13404","DOI":"10.1038\/s41598-017-13332-0","volume":"7","author":"YM Ling","year":"2017","unstructured":"Ling YM, Chen JY, Guo L, et al. \u03b2-defensin 1 expression in HCV infected liver\/liver cancer: an important role in protecting HCV progression and liver cancer development. Sci Rep. 2017;7:13404. https:\/\/doi.org\/10.1038\/s41598-017-13332-0.","journal-title":"Sci Rep"},{"key":"2340_CR30","first-page":"1365","volume":"26","author":"X Li","year":"2021","unstructured":"Li X, Song W, Zhang M, et al. Human \u03b2-defensin 1 functions as a tumor suppressor via ER stress-triggered JNK pathway in hepatocellular carcinoma. J Buon. 2021;26:1365\u201372.","journal-title":"J Buon"},{"key":"2340_CR31","doi-asserted-by":"publisher","first-page":"18043","DOI":"10.1038\/s41598-018-36387-z","volume":"8","author":"C Bonamy","year":"2018","unstructured":"Bonamy C, Sechet E, Amiot A, et al. Expression of the human antimicrobial peptide \u03b2-defensin-1 is repressed by the EGFR-ERK-MYC axis in colonic epithelial cells. Sci Rep. 2018;8:18043. https:\/\/doi.org\/10.1038\/s41598-018-36387-z.","journal-title":"Sci Rep"},{"key":"2340_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/82_2010_46","volume":"344","author":"WH Fridman","year":"2011","unstructured":"Fridman WH, Galon J, Dieu-Nosjean MC, et al. Immune infiltration in human cancer: prognostic significance and disease control. Curr Top Microbiol Immunol. 2011;344:1\u201324. https:\/\/doi.org\/10.1007\/82_2010_46.","journal-title":"Curr Top Microbiol Immunol"},{"key":"2340_CR33","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1126\/science.286.5439.525","volume":"286","author":"D Yang","year":"1999","unstructured":"Yang D, Chertov O, Bykovskaia SN, et al. \u03b2-Defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science. 1999;286:525\u20138. https:\/\/doi.org\/10.1126\/science.286.5439.525.","journal-title":"Science"},{"key":"2340_CR34","doi-asserted-by":"publisher","first-page":"6644","DOI":"10.4049\/jimmunol.167.11.6644","volume":"167","author":"A Biragyn","year":"2001","unstructured":"Biragyn A, Surenhu M, Yang D, et al. Mediators of innate immunity that target immature, but not mature, dendritic cells induce antitumor immunity when genetically fused with nonimmunogenic tumor antigens. J Immunol. 2001;167:6644\u201353. https:\/\/doi.org\/10.4049\/jimmunol.167.11.6644.","journal-title":"J Immunol"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-02340-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-02340-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-02340-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T10:39:09Z","timestamp":1744886349000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-02340-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,17]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2340"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-02340-6","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,17]]},"assertion":[{"value":"2 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Ethics Committee of Tianjin Medical University Cancer Institute & Hospital (Approval No. EK20240003). All the experiments in this study were conducted in compliance with the Declaration of Helsinki. The patients\/participants provided their written informed consent to participate in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"552"}}